The Cancer Institute of New Jersey (CINJ) is a matrix style cancer center under the auspices of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. The Director serves as Associate Dean for Oncology Programs and is responsible for integrated research at the medical school with the Robert Wood Johnson University Hospital, the St. Peter's University Hospital, and several schools and departments of Rutgers University. CINJ was awarded its first P30 Cancer Support Grant (CA72720) on March 1, 1997. CINJ has 124 members, whose peer-reviewed, funded research projects, as defined by the CCSG guidelines, total more than $26.5 million in annual direct costs, over $6 million of which is from the NCI. The research base of CINJ is organized into seven programs: Cancer Pharmacology; Carcinogenesis and Chemoprevention; Molecular Mechanisms of Tumor Growth; Cytokines, Growth Factors, and Signal Transduction: Transcriptional Regulation and Oncogenesis; Clinical Investigations; and Cancer Control. With this application, CINJ has added programmatic strength in Population Science through two programs, Carcinogenesis and Chemoprevention, and Cancer Control. This application requests support for the following: Senior Leadership; Major Program Leaders; Planning and Evaluation; Developmental Funds; Administration; Clinical Protocol Scientific Review and Monitoring; and Protocol Specific Research. In addition, we are requesting funds for the following shared resources of CINJ: Analytical Cytometry; DNA Synthesis and Sequencing; Laboratory Support Services; Immunohistochemistry; Tissue Retrieval Service; Biometrics; Research Pharmacy; and Clinical Research Office.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA072720-06
Application #
6513040
Study Section
Subcommittee G - Education (NCI)
Program Officer
Silkensen, Shannon M
Project Start
2000-04-06
Project End
2005-02-28
Budget Start
2002-03-01
Budget End
2003-02-28
Support Year
6
Fiscal Year
2002
Total Cost
$2,316,196
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Patrizii, Michele; Bartucci, Monica; Pine, Sharon R et al. (2018) Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy. Front Oncol 8:23
Herman, Joseph M; Jabbour, Salma K; Lin, Steven H et al. (2018) Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. Pancreas 47:208-212
CeliĆ -Terrassa, Toni; Bastian, Caleb; Liu, Daniel et al. (2018) Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nat Commun 9:5005
Zloza, Andrew (2018) Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancer. J Immunother Cancer 6:3
George, Blessy; Joy, Melanie S; Aleksunes, Lauren M (2018) Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood) 243:272-282
Paratala, Bhavna S; Chung, Jon H; Williams, Casey B et al. (2018) RET rearrangements are actionable alterations in breast cancer. Nat Commun 9:4821
Jian-Yu E; Graber, Judith M; Lu, Shou-En et al. (2018) Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis. Curr Med Chem 25:2595-2607
Moloughney, Joseph G; Vega-Cotto, Nicole M; Liu, Sharon et al. (2018) mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. J Biol Chem 293:16464-16478
Zhu, Sining; Jin, Juan; Gokhale, Samantha et al. (2018) Genetic Alterations of TRAF Proteins in Human Cancers. Front Immunol 9:2111
Perekatt, Ansu O; Shah, Pooja P; Cheung, Shannon et al. (2018) SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res 78:4878-4890

Showing the most recent 10 out of 775 publications